SALVA LA DATA 🚨 📺 Lunedì 23 giugno – Ore 19:00 🕖 Su IGNIS Tv 🎤 Una testimonianza potente. Una voce fuori dal coro. Una verità da ascoltare. In diretta con noi Paola Fara, autrice del libro che sta facendo riflettere l’Italia: 📘 **“Gocce dello stesso mare. In cammino con i danneggiati del vaccino anti Covid-19”. Un’intervista da non perdere, per chi ha a cuore la verità, la giustizia e il coraggio di chi, nel silenzio generale, ha subito – e continua a subire – le conseguenze di scelte imposte in nome dell’emergenza. 💔 Storie vere di dolore e invisibilità. 🧭 Un viaggio umano tra coscienze dimenticate. ⚖️ Una riflessione profonda sui diritti sospesi, sulle parole mai dette e su una memoria collettiva da ricostruire. 👉 Condividi, partecipa, ascolta. Perché solo dando voce a chi non ce l’ha, possiamo davvero voltare pagina. 📲 Lunedì 23 giugno alle 19:00 – solo su IGNIS Tv #GocceDelloStessoMare #PaolaFara #IGNISTv #VeritàEDiritti #PostCovid #DanneggiatiDaVaccino #LibertàDiAscoltare #IntervistaEsclusiva #VeritàScomode https://www.youtube.com/live/6yQ78nMVnqg?si=2kfpWhZZknHz6b6H

‼️Presentato in Tribunale dell’Unione Europea ricorso di annullamento dell’autorizzazione della sostanza sperimentale altamente pericolosa KOSTAIVE-Zapomeran, basata sull’RNA autoamplificante, con richiesta di provvedimento cautelare. MASSIMA DIFFUSIONE! Il 9 giugno 2025, nella mia funzione istituzionale di membro del Consiglio Provinciale del Sudtirolo/Alto Adige, ho presentato al Tribunale dell’Unione Europea un ricorso di annullamento ai sensi dell’articolo 263 TFUE contro la decisione della Commissione europea del 12 febbraio 2025 con cui è stata autorizzata come “vaccino”-Covid-19 la sostanza sperimentale KOSTAIVE-Zapomeran, basata sull’ingegneria genetica e costituita da RNA auto-amplificante. L’autorizzazione di KOSTAIVE è stata concessa senza che fossero stati effettuati studi essenziali per le sostanze basate sull’ingegneria genetica. Per KOSTAIVE non sono stati studiati né esclusi la genotossicità, la carcinogenicità, la mutagenicità (alterazione del DNA), né la trasmissibilità all’ambiente. Ciò è stato possibile perché nel 2009 la Commissione europea, sotto la presidenza di Josè Emanuel Barroso, ha escluso le sostanze dichiarate formalmente come “vaccini contro le malattie infettive” dall’applicazione delle severe norme di autorizzazione previste per i prodotti di terapia genica, a seguito dell’intervento dell’industria farmaceutica. I dettagli e i documenti relativi a questo procedimento criminale sono contenuti nel ricorso di annullamento. Non sorprende, quindi, che l’allora presidente della Commissione europea Barroso sia ora i CEO dell’alleanza per i vaccini GAVI e quindi il massimo lobbista dell’industria dei vaccini. Il KOSTAIVE comporta gravi rischi per la salute e la vita della popolazione dell’UE. Già dal foglietto illustrativo emerge che esiste il rischio di miocardite e pericardite. Esperti in posizioni istituzionali, come il direttore del Centro Nazionale per la Salute Globale presso l’Istituto Superiore di Sanità, temono che l’RNA auto-amplificante di KOSTAIVE possa essere trasmesso attraverso vescicole extracellulari (EV) all’intero ambiente, e dunque anche alle persone non trattate con KOSTAIVE e a tutti gli animali (le EV non conoscono barriere di specie). Il rispettivo articolo scientifico pubblicato dal dott. Maurizio Federico (e finanziato dal Ministero della Salute) è stato allegato come doc. 6 al ricorso di annullamento. Pertanto, il principio della necessità del libero consenso al trattamento farmacologico, sancito dal diritto internazionale, dal diritto dell’Unione Europea e dalle Carte Costituzionali degli Stati membri dell’Unione Europea, è stato di fatto abolito dalla Commissione Europea con l’autorizzazione di questa pericolosa sostanza sperimentale geneticamente modificata con rilevanza penale! I motivi per cui in questo caso ogni singolo cittadino dell’UE ha la legittimazione ad agire dinanzi al Tribunale europeo sono riportati in dettaglio nel ricorso di annullamento. Data l’estrema urgenza della questione (è in gioco la salute e la vita di tutti i cittadini dell’UE!), è stata presentata anche un’istanza di provvedimento cautelare e la richiesta per l’adozione del procedimento accelerato. I cittadini dell’UE, rappresentati da avvocati, possono partecipare al procedimento, che pende con T-375/27, in qualità di intervenienti. ‼️Lawsuit Filed at the European Union Court to Annul Authorization of the Highly Dangerous Experimental Substance KOSTAIVE-Zapomeran, Based on Self-Amplifying RNA, with Request for Interim Measures On June 9, 2025, in my official capacity as a member of the Provincial Council of South Tyrol/Alto Adige, I filed an annulment lawsuit under Article 263 TFEU at the Court of Justice of the European Union against the European Commission’s decision of February 12, 2025, which authorized the experimental substance KOSTAIVE-Zapomeran—a genetically engineered, self-amplifying RNA-based product—as a "Covid-19 vaccine." The authorization of KOSTAIVE was granted **without conducting essential studies required for genetically engineered substances. For **KOSTAIVE, genotoxicity, carcinogenicity, mutagenicity (DNA alteration), and environmental transmission were neither studied nor ruled out. This was possible because, in 2009, under the presidency of José Manuel Barroso, the European Commission excluded substances formally declared as "vaccines against infectious diseases" from the strict authorization rules applied to gene therapy products, following pressure from the pharmaceutical industry. The details and documents regarding this criminal proceeding are included in the annulment lawsuit. Unsurprisingly, the former European Commission President Barroso is now the CEO of the vaccine alliance GAVI and thus the top lobbyist for the vaccine industry. KOSTAIVE poses serious risks to the health and lives of EU citizens. Even the package leaflet acknowledges the risk of myocarditis and pericarditis. Experts in institutional positions, such as the Director of the National Center for Global Health at the Italian National Health Institute (Istituto Superiore di Sanità), fear that the self-amplifying RNA in KOSTAIVE could be transmitted through extracellular vesicles (EVs) to the entire environment, including people not treated with KOSTAIVE and all animals (since EVs do not respect species barriers). The scientific article published by Dr. Maurizio Federico (and funded by the Italian Ministry of Health) was attached as Document 6 to the annulment lawsuit. Thus, the principle of free and informed consent to medical treatment, enshrined in international law, EU law, and the constitutions of EU member states, has been effectively abolished by the European Commission** through the authorization of this dangerous, genetically modified experimental substance, which carries potential criminal liability! The reasons why every single EU citizen has standing to bring this case before the European Court are detailed in the annulment lawsuit. Given the extreme urgency of the matter (the health and lives of all EU citizens are at stake!), a request for interim measures and an expedited procedure has also been filed. EU citizens, represented by lawyers, can join the proceedings (Case T-375/27) as interveners. https://www.renate-holzeisen.eu/it/presentato-ricorso-di-annullamento-dellautorizzazione-come-vaccino-della-sostanza-sperimentale-kostaive-zapomeran-con-istanza-cautelare/?amp=1

Mons. Carlo Maria Viganò (@CarloMVigano ): L'azione di Bergoglio nella Chiesa è stata l'indispensabile corollario del golpe sanitario dell'OMS finanziato da Bill Gates e dalle case farmaceutiche. Lo scopo era l'inoculazione di un siero a tecnologia mRNA che inducesse modifiche a livello genetico, distruggesse il sistema immunitario, provocasse gravi patologie tra cui tumori e sterilità, e in molti casi fosse mortale. Oggi la pericolosità dei sieri spacciati per vaccini miracolosi è confermata dall'ammissione di chi li ha distribuiti e imposti. La loro illiceità morale era data anche dalla presenza di tessuti fetali, non solo per produrre l'antigene, ma anche per replicarli. L'autorizzazione al loro uso da parte del Dicastero per la Dottrina della Fede (che all'epoca contestai con un ampia documentazione) costituisce la prova della complicità della chiesa Bergogliana al piano di depopolazione perseguito dall'Agenda 2030 #radioroma

Mons. Carlo Maria Viganò (@CarloMVigano ): L'azione di Bergoglio nella Chiesa è stata l'indispensabile corollario del golpe sanitario dell'OMS finanziato da Bill Gates e dalle case farmaceutiche. Lo scopo era l'inoculazione di un siero a tecnologia mRNA che inducesse modifiche a livello genetico, distruggesse il sistema immunitario, provocasse gravi patologie tra cui tumori e sterilità, e in molti casi fosse mortale. Oggi la pericolosità dei sieri spacciati per vaccini miracolosi è confermata dall'ammissione di chi li ha distribuiti e imposti. La loro illiceità morale era data anche dalla presenza di tessuti fetali, non solo per produrre l'antigene, ma anche per replicarli. L'autorizzazione al loro uso da parte del Dicastero per la Dottrina della Fede (che all'epoca contestai con un ampia documentazione) costituisce la prova della complicità della chiesa Bergogliana al piano di depopolazione perseguito dall'Agenda 2030 #radioroma Source: https://x.com/itsmeback_/status/1936032333078893016

Advanced Contactless Smart Cards | Chip Card Technology Discover our range of contactless smart cards and contactless chip cards, designed to deliver fast, secure, and hassle-free solutions for modern transactions and access management. Whether for secure identification, cashless payments, or entry control systems, our advanced contactless technology ensures reliability and data protection across various industries. With seamless integration capabilities and enhanced user convenience, these cards are ideal for businesses, educational institutions, hospitality, and government sectors. Elevate your security and operational efficiency with our innovative card solutions tailored to your needs. Learn more about the benefits and applications of contactless cards here: https://www.id-smartcards.com/blog/contactless-smart-cards-chip-cards/

Free ZIP File Converter: Easily Compress and Extract Files Online In today’s digital world, managing file sizes is essential. Whether you're sharing documents, organizing your storage, or uploading data, ZIP files are one of the most efficient ways to compress and group multiple files. But what if you don’t have the right software to handle them? That’s where a free ZIP file converter comes in handy. In this article, we’ll explore how ZIP file converters work, why you need them, and where you can find the best free ZIP file converter online. Visit Now: https://hamaytools.com

Data Engineering Company in India At Nest Software, we understand the power of data in transforming your business. As a leading Data Engineering Company in India, we specialize in creating efficient and scalable data solutions that help you unlock meaningful insights. Our expertise in data architecture and real-time analytics empowers your business to make informed decisions and stay ahead of the curve. Ready to make your data work for you? Visit our website to learn how we can help you achieve greater business success with smarter data engineering. https://nspl.co.in/data-engineering-company-india/

Cloud Services Company in India Nest Software is your trusted Cloud Services company in India, offering scalable solutions for data storage and management without the need for physical infrastructure. Our team of cloud experts ensures seamless integration, flexibility, and cost-effective solutions tailored to fit your business needs. With a focus on security, performance, and value, we help you navigate the complexities of the cloud with ease. https://nspl.co.in/cloud-services-company-india/

Analyzing the Animal Wound Care Market: Size, Share, and Growth Projections 2024-2030 MarkNtel Advisors recently published a detailed industry analysis of the Animal Wound Care Market. The report covers growth trends, regional marketing strategies, challenges, opportunities, and drivers influencing the market. ✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report. Insights and Analysis of the Animal Wound Care Market (2024-2030) The Global Animal Wound Care Market size was valued at around USD 1.24 billion in 2023 & is estimated to grow at a CAGR of about 8.5% during the forecast period, i.e., 2024–30. Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/interactive-kiosk-market.html Global Animal Wound Care Market Driver: Rising Awareness of Animal Health – The growing consciousness surrounding animal health has emerged as a key factor fueling the expansion of the animal wound care market. With a rise in pet ownership and heightened demand for livestock production, there's an increasing acknowledgment of the importance of preserving optimal health in animals. According to the American Veterinary Medical Association Report, it has been observed that a significant rise in pet ownership in the U.S. reached around 75 million dogs and 80 million cats in domiciliary areas. This rising population of pets results in a greater emphasis on veterinary care, specifically for wound and injury treatment. Additionally, the World Organization for Animal Health (OIE) underscores the critical role of animal health in global food security, stressing the necessity of efficient wound care in livestock to uphold sustainable agriculture. The understanding of zoonotic diseases and the interdependency between animal and human health further accentuates the demand for resilient animal wound care remedies. The international marketplace is undergoing notable advancements in animal wound care as major players allocate resources to research & development. These companies are bringing forth innovative solutions, including cutting-edge wound dressings and healing agents, to cater to the diverse requirements of animals. What segments define the Animal Wound Care market from 2024 to 2030? How do these segments contribute to market dynamics and growth? -By Product -Surgical Wound Care Products- Market Size & Forecast 2019-2030, (USD Million) -Sutures and Staplers- Market Size & Forecast 2019-2030, (USD Million) -Tissues Adhesives, Sealants, and Glues- Market Size & Forecast 2019-2030, (USD Million) -Advanced Wound Care Products- Market Size & Forecast 2019-2030, (USD Million) -Foam Dressings- Market Size & Forecast 2019-2030, (USD Million) -Hydrocolloid Dressings- Market Size & Forecast 2019-2030, (USD Million) -Film Dressings- Market Size & Forecast 2019-2030, (USD Million) -Hydrogel Dressings- Market Size & Forecast 2019-2030, (USD Million) -Others- Market Size & Forecast 2019-2030, (USD Million) -Traditional Wound Care Products- Market Size & Forecast 2019-2030, (USD Million) -Tapes- Market Size & Forecast 2019-2030, (USD Million) -Dressings- Market Size & Forecast 2019-2030, (USD Million) -Bandages- Market Size & Forecast 2019-2030, (USD Million) -Absorbents- Market Size & Forecast 2019-2030, (USD Million) -Others- Market Size & Forecast 2019-2030, (USD Million) -Therapy Devices- Market Size & Forecast 2019-2030, (USD Million) -By Animal Type -Companion Animals- Market Size & Forecast 2019-2030, (USD Million) -Dogs- Market Size & Forecast 2019-2030, (USD Million) -Cats- Market Size & Forecast 2019-2030, (USD Million) -Horses- Market Size & Forecast 2019-2030, (USD Million) -Others- Market Size & Forecast 2019-2030, (USD Million) -Livestock Animals- Market Size & Forecast 2019-2030, (USD Million) -Cattle- Market Size & Forecast 2019-2030, (USD Million) -Pigs- Market Size & Forecast 2019-2030, (USD Million) -Poultry- Market Size & Forecast 2019-2030, (USD Million) -Others- Market Size & Forecast 2019-2030, (USD Million) -By End-User -Hospitals & Clinics- Market Size & Forecast 2019-2030, (USD Million) -Home Care Settings- Market Size & Forecast 2019-2030, (USD Million) -By Region -North America -South America -Europe -The Middle East & Africa -Asia-Pacific Explore the Complete Animal Wound Care Market Analysis Report – https://www.marknteladvisors.com/research-library/animal-wound-care-market.html Who are the leading key players shaping the Animal Wound Care Market landscape? Elanco Animal Health, 3M Company, Medtronic PLC, B. Braun Melsungen Ag, Virbac, Neogen Corporation, Jorgen Kruuse A/S, Sonoma Pharmaceuticals Inc., Ehicon, Inc., Dechra Pharmaceuticals, Jazz Medical, LLC, Smith & Nephew PLC, Care-Tech Laboratories, Inc., Others, Questions Addressed in this Study 1.What factors are driving the Animal Wound Care Market growth? 2.What are the key insights into the current trends in the Animal Wound Care Market? 3.What is the current size of the Animal Wound Care Market, and how is it projected to change in the future? 4.What is the future outlook for the Animal Wound Care Market in terms of technological advancements and market expansion? For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/animal-wound-care-market.html “Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.” Why MarkNtel Advisors? MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others. Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals. For Media Inquiries, Please Contact: Email: sales@marknteladvisors.com Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Fractional CFO E-commerce Without profits, a business cannot survive. That’s why our Blueprint CFO team creates a data-driven Profitability Roadmap™ for clients, so they can thrive! Click here- https://blueprintcfo.com/fractional-cfo/